Status:
COMPLETED
PROPACT: Retrospective Prophylaxis Patient Case Collection
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Congenital Bleeding Disorder
Haemophilia A With Inhibitors
Eligibility:
MALE
Brief Summary
This study is conducted in Europe and North and South America. The primary aim of this observational study is to evaluate the frequency and pattern of bleeding episodes in haemophilia patients receivi...
Eligibility Criteria
Inclusion
- Haemophilia A or B with inhibitors
- Prescribed use of activated recombinant human factor VII for any type of prophylaxis with a duration of at least 30 days
Exclusion
- Prophylaxis prescribed post-surgery
- One or more coagulation disorders in addition to haemophilia
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00882778
Start Date
April 1 2009
End Date
May 1 2010
Last Update
January 9 2017
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Princeton, New Jersey, United States, 08540
2
Novo Nordisk Investigational Site
Prov. de Buenos Aires, Argentina, B1636DSU
3
Novo Nordisk Investigational Site
Mississauga, Canada, L4W 4XI
4
Novo Nordisk Investigational Site
Zagreb, Croatia, 10 000